Postmarketing surveillance for drug abuse. 2003

Cynthia L Arfken, and Theodore J Cicero
Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, 2761 E. Jefferson, Detroit, MI 48207, USA. carfken@med.wayne.edu

Assessing actual abuse of prescribed medications requires postmarketing surveillance. In this article we discuss general systems of postmarketing surveillance that exist as of the end of 2002 in the United States and two medication-specific surveillance systems that were devised and tested. The two specific surveillance systems are compared with limitations highlighted. Postmarketing surveillance is in its infancy and requires more research on ways to improve its validity without inducing illicit experimentation. Information on comparator medications is highly recommended both to validate the system and to place the results in context.

UI MeSH Term Description Entries
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D011358 Product Surveillance, Postmarketing Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale. Drug Surveillance, Postmarketing,Evaluation Studies, Postmarketing,Postmarketing Product Surveillance,Product Surveillance, Post-Marketing,Drug Surveillances, Postmarketing,Evaluation Study, Postmarketing,Post-Marketing Product Surveillance,Post-Marketing Product Surveillances,Postmarketing Drug Surveillance,Postmarketing Drug Surveillances,Postmarketing Evaluation Studies,Postmarketing Evaluation Study,Postmarketing Product Surveillances,Product Surveillance, Post Marketing,Product Surveillances, Post-Marketing,Product Surveillances, Postmarketing,Studies, Postmarketing Evaluation,Study, Postmarketing Evaluation,Surveillance, Post-Marketing Product,Surveillance, Postmarketing Drug,Surveillance, Postmarketing Product,Surveillances, Post-Marketing Product,Surveillances, Postmarketing Drug,Surveillances, Postmarketing Product
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001067 Appetite Depressants Agents that are used to suppress appetite. Anorectic,Anorectic Agent,Anorectics,Anorexic Drug,Anorexigenic Drug,Appetite Depressant,Appetite Suppressant,Appetite Suppressants,Appetite-Depressing Drug,Appetite-Suppressant Drug,Anorectic Agents,Anorexic Drugs,Anorexigenic Drugs,Appetite-Depressing Drugs,Appetite-Suppressant Drugs,Agent, Anorectic,Agents, Anorectic,Appetite Depressing Drug,Appetite Depressing Drugs,Appetite Suppressant Drug,Appetite Suppressant Drugs,Depressant, Appetite,Depressants, Appetite,Drug, Anorexic,Drug, Anorexigenic,Drug, Appetite-Depressing,Drug, Appetite-Suppressant,Drugs, Anorexic,Drugs, Anorexigenic,Drugs, Appetite-Depressing,Drugs, Appetite-Suppressant,Suppressant, Appetite,Suppressants, Appetite
D014147 Tramadol A narcotic analgesic proposed for severe pain. It may be habituating. Adolonta,Amadol,Biodalgic,Biokanol,Contramal,Jutadol,K-315,MTW-Tramadol,Nobligan,Prontofort,Ranitidin 1A Pharma,Takadol,Theradol,Tiral,Topalgic,Tradol,Tradol-Puren,Tradonal,Tralgiol,Trama 1A Pharma,Trama AbZ,Trama KD,Trama-Dorsch,Tramabeta,Tramadin,Tramadoc,Tramadol 1A,Tramadol AL,Tramadol Asta Medica,Tramadol Basics,Tramadol Bayvit,Tramadol Bexal,Tramadol Cinfa,Tramadol Edigen,Tramadol Heumann,Tramadol Hydrochloride,Tramadol Kern,Tramadol Lichtenstein,Tramadol Lindo,Tramadol Mabo,Tramadol Normon,Tramadol PB,Tramadol Ratiopharm,Tramadol Stada,Tramadol acis,Tramadol-Dolgit,Tramadol-Hameln,Tramadol-ratiopharm,Tramadolor,Tramadura,Tramagetic,Tramagit,Tramake,Tramal,Tramex,Tramundin,Trasedal,Ultram,Xymel 50,Zamudol,Zumalgic,Zydol,Zytram,K 315,K315,MTW Tramadol,MTWTramadol,Tradol Puren,TradolPuren,Trama Dorsch,TramaDorsch,Tramadol Dolgit,Tramadol Hameln,TramadolDolgit,TramadolHameln,Tramadolratiopharm
D016907 Adverse Drug Reaction Reporting Systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. Adverse Drug Reaction Reporting System,Drug Reaction Reporting Systems, Adverse
D017277 Drug Approval Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. Drug Approval Process,New Drug Approval,Food and Drug Administration Drug Approval,Food and Drug Administration Drug Approval Process,New Drug Approval Process,Approval Process, Drug,Approval Processes, Drug,Approval, Drug,Approval, New Drug,Approvals, Drug,Approvals, New Drug,Drug Approval Processes,Drug Approval, New,Drug Approvals,Drug Approvals, New,New Drug Approvals,Process, Drug Approval,Processes, Drug Approval
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

Cynthia L Arfken, and Theodore J Cicero
December 1979, Journal of pharmaceutical sciences,
Cynthia L Arfken, and Theodore J Cicero
February 1984, JAMA,
Cynthia L Arfken, and Theodore J Cicero
November 2004, Clinical pharmacology and therapeutics,
Cynthia L Arfken, and Theodore J Cicero
May 1991, Clinical pharmacology and therapeutics,
Cynthia L Arfken, and Theodore J Cicero
March 2003, Drug and alcohol dependence,
Cynthia L Arfken, and Theodore J Cicero
May 1984, British medical journal (Clinical research ed.),
Cynthia L Arfken, and Theodore J Cicero
January 1998, Clinical therapeutics,
Cynthia L Arfken, and Theodore J Cicero
December 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Cynthia L Arfken, and Theodore J Cicero
January 1994, Pharmacotherapy,
Copied contents to your clipboard!